Answers are grounded in this paper and cite their sources.
Demonstrates the mechanisms of perfluorocarbon emulsions for in vivo oxygen delivery and diagnostic imaging, highlighting clinical efficacy despite past trial suspensions.
The unique behavior of perfluorocarbons (PFCs), including their high oxygen dissolving capacity, hydrophobic and lipophobic character, and extreme inertness, derive directly, in a predictable manner, from the electronic structure and spatial requirements of the fluorine atom. Their low water solubility is key to the prolonged in vivo persistence of the now commercially available injectable microbubbles that serve as contrast agents for diagnostic ultrasound imaging. Oxygent, a stable, small-sized emulsion of a slightly lipophilic, rapidly excreted PFC, perfluorooctyl bromide (perflubron), has been engineered. Significant oxygen delivery has been established in animal models and through Phase II and III human clinical trials. However, an inappropriate testing protocol and the lack of funding led to temporary suspension of the trials.
No takes yet. Share an insight, caveat, or question.
Jean G. Riess (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: